Santa Cruz Biotechnology now offers a broad range of GABA B R2 Inhibitors for use in various applications. GABA B receptors, particularly those involving the R2 subunit, are metabotropic receptors that play a crucial role in the regulation of inhibitory neurotransmission within the central nervous system. Unlike the fast-acting ionotropic GABA A receptors, GABA B receptors are G-protein-coupled receptors that modulate synaptic activity through slower, longer-lasting effects. GABA B R2 Inhibitors are essential tools in scientific research, allowing researchers to selectively block these receptors to explore their role in modulating neural excitability, synaptic transmission, and neurotransmitter release. By inhibiting GABA B R2, scientists can investigate how these receptors influence physiological processes such as pain perception, motor coordination, and cognitive functions, and how their disruption might contribute to neurological conditions. These inhibitors are widely used in neurophysiological studies, behavioral research, and pharmacological experiments to understand the broader implications of altered GABA B signaling in brain function and behavior. Additionally, GABA B R2 Inhibitors are valuable for studying the interactions between GABA B receptors and other signaling pathways, providing insights into the complex regulatory mechanisms that maintain neural homeostasis. The availability of these inhibitors has significantly advanced research in neurobiology and neuroscience, offering critical tools for dissecting the intricate dynamics of inhibitory neurotransmission and its impact on overall brain function. View detailed information on our available GABA B R2 Inhibitors by clicking on the product name.